Estamos realizando la búsqueda. Por favor, espere...
1583
37
170
29013
4402
2599
347
386
Abstract: Multiple myeloma remains largely incurable. However, a few patients experience more than 10 years of relapse-free survival and can be considered as operationally cured. Interestingly, long-term disease control in multiple myeloma is not restricted to patients with a complete response, since some patients revert to having a profile of monoclonal gammopathy of undetermined significance. We compared the distribution of multiple compartments of lymphocytes and dendritic cells in the bone marrow and peripheral blood of multiple myeloma patients with long-term disease control (n=28), patients with newly diagnosed monoclonal gammopathy of undetermined significance (n=23), patients with symptomatic multiple myeloma (n=23), and age-matched healthy adults (n=10). Similarly to the patients with monoclonal gammopathy of undetermined significance and symptomatic multiple myeloma, patients with long-term disease control showed an expansion of cytotoxic CD8(+) T cells and natural killer cells. However, the numbers of bone marrow T-regulatory cells were lower in patients with long-term disease control than in those with symptomatic multiple myeloma. It is noteworthy that B cells were depleted in patients with monoclonal gammopathy of undetermined significance and in those with symptomatic multiple myeloma, but recovered in both the bone marrow and peripheral blood of patients with long-term disease control, due to an increase in normal bone marrow B-cell precursors and plasma cells, as well as pre-germinal center peripheral blood B cells. The number of bone marrow dendritic cells and tissue macrophages differed significantly between patients with long-term disease control and those with symptomatic multiple myeloma, with a trend to cell count recovering in the former group of patients towards levels similar to those found in healthy adults. In summary, our results indicate that multiple myeloma patients with long-term disease control have a constellation of unique immune changes favoring both immune cytotoxicity and recovery of B-cell production and homing, suggesting improved immune surveillance.
Fuente: Haematologica, 2013, 98(1), 79-86
Editorial: Ferrata Storti Foundation
Año de publicación: 2013
Nº de páginas: 8
Tipo de publicación: Artículo de Revista
DOI: 10.3324/haematol.2012.067272
ISSN: 0390-6078,1592-8721
Consultar en UCrea Leer publicación
DE MAGALHÃES, ROBERTO J. PESSOA
VIDRIALES, MARÍA-BELÉN
PAIVA, BRUNO
FERNANDEZ-GIMENEZ, CARLOS
GARCÍA-SANZ, RAMÓN
MATEOS, MARIA-VICTORIA
GUTIERREZ, NORMA C.
LECREVISSE, QUENTIN
BLANCO, JUAN F.
HERNÁNDEZ, JOSE
DE LAS HERAS, NATALIA
MARTINEZ-LOPEZ, JOAQUIN
ROIG, MONICA
COSTA, ELAINE SOBRAL
ENRIQUE MARIA OCIO SAN MIGUEL
PEREZ-ANDRES, MARTIN
MAIOLINO, ANGELO
NUCCI, MARCIO
DE LA RUBIA, JAVIER
LAHUERTA, JUAN-JOSE
Volver